drugset / Trial / NCT01293682

Effects of High Dose Calcitriol in Breast Cancer Patients

NCT01293682

Phase 2 Completed 12 enrolled University of Rochester
NaSingle-groupOpen-labelPrevention

Summary

This research will examine the effectiveness of calcitriol in treating bone loss in women who are about to begin treatment for breast cancer. Twenty-five (25) subjects are expected to take part in this study. The investigators don't know if bone loss in breast cancer survivors should be treated differently than bone loss in other women.

Timeline

Start
2010-11
Primary completion
2018-08
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcitriol Small molecule 45 ug Oral

Indications